-
drug development, with strong potential for publication in high-impact journals. Our research aims to uncover fundamental mechanisms of leukemogenesis and solid tumor progression, with a particular
-
areas: Investigating the biological mechanisms underlying tumor progression: We use single-cell and bulk multiomic techniques to profile tumor samples, focusing on resistance mechanisms in breast cancer
-
of medicine through cutting-edge research. Leveraging multiomics, mouse genetics, hiPS cells, and electrophysiology, our lab works on molecular mechanism of cardiometabolic oncology. The postdoctoral fellow
-
. The project involves both in vitro and in vivo studies to uncover the molecular and cellular mechanisms driving cancer-associated immunosuppression using mouse and human solid tumor models. Additionally
-
through cutting-edge research. Join Dr. Marcel van den Brink’s multidisciplinary team to explore innovative ways to decipher the molecular mechanisms by which the microbiome contributes to the biology of
-
have been focused on exploring the molecular mechanisms of leukemogenesis and evolution, discovery of novel therapeutic targets, and development of novel therapeutic strategies, including novel
-
. Understanding fundamental mechanism of RNA metabolism including splicing and modification is required. Familiar with murine models is preferred. Excellent verbal and written communication skills. Self-motivated
-
the biological mechanisms linking cardiovascular diseases with cancer and cancer therapies. She uses human-induced pluripotent stem cells (iPSCs), patient-derived samples, genomics, and computational biology to
-
proteins in phase separation: Investigate the biological function and molecular mechanism of RNA modifications and RNA-binding proteins-driven phase separation in tumorigenesis, with a focus on
-
deciphering their underlying molecular mechanisms in normal developmental processes and tumorigenesis. We cover research areas with relevance to RNA Biology, Cancer Biology, Chromatin Regulation, Cancer